Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors

This study aims to show the application of flexible statistical methods in real-world cost-effectiveness analyses applied in the cardiovascular field, focusing specifically on the use of proprotein convertase subtilisin-kexin type 9 inhibitors for hyperlipidemia. The proposed method allowed us to us...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2024-07, Vol.27 (7), p.897-906
Hauptverfasser:	Gregorio, Caterina, Rea, Federico, Ieva, Francesca, Scagnetto, Arjuna, Indennidate, Carla, Cappelletto, Chiara, Di Lenarda, Andrea, Barbati, Giulia
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Computer Simulation Cost-Benefit Analysis cost-effectiveness electronic health records Female Humans Hyperlipidemias - drug therapy Hyperlipidemias - economics Male Markov Chains microsimulation Middle Aged Models, Economic PCSK9 Inhibitors Proprotein Convertase 9 Quality-Adjusted Life Years real-world data target trial emulation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!